Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...
TipRanks on MSN19h
Bonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug TrialBonus Biogroup has received FDA approval for an IND application to conduct a Phase III clinical trial of a drug designed to treat acute respiratory distress syndrome (ARDS), especially in severe COVID ...
One Health is a global initiative led by the 'Quadripartite' to address health risks at the human-animal-ecosystems interface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback